Abstract
In cancer imaging, many different modalities are used that each have their specific features, leading to the combined use of different techniques for the detection, staging and treatment evaluation of cancer. Optical imaging using near-infrared fluorescence light is a new imaging modality that has recently emerged in the field of cancer imaging. After extensive preclinical research, the first steps of translation to the clinical practice are currently being made. In this article, we discuss the preclinical and clinical results of near-infrared optical imaging for non-invasive detection and classification of tumors, therapy monitoring, sentinel lymph node procedures, and image-guided cancer surgery. Widespread availability of imaging systems and optical contrast agents will enable larger studies on their clinical benefit and can help establish a definitive role in clinical practice.
Keywords: Image-guided surgery, near-infrared fluorescence, optical imaging, translational research, preclinical and clinical results, visualizing anatomy, computed tomography (CT), magnetic resonance imaging (MRI), clinical practice, positron emission tomography (PET), single-photon-emission computed tomography (SPECT), image anatomical, hemoglobin, absorption coefficient, hypermetabolism
Current Pharmaceutical Biotechnology
Title: Translational Optical Imaging in Diagnosis and Treatment of Cancer
Volume: 13 Issue: 4
Author(s): Stijn Keereweer, Merlijn Hutteman, Jeroen D.F. Kerrebijn, Cornelis J.H. van de Velde, Alexander L. Vahrmeijer and Clemens W.G.M. Lowik
Affiliation:
Keywords: Image-guided surgery, near-infrared fluorescence, optical imaging, translational research, preclinical and clinical results, visualizing anatomy, computed tomography (CT), magnetic resonance imaging (MRI), clinical practice, positron emission tomography (PET), single-photon-emission computed tomography (SPECT), image anatomical, hemoglobin, absorption coefficient, hypermetabolism
Abstract: In cancer imaging, many different modalities are used that each have their specific features, leading to the combined use of different techniques for the detection, staging and treatment evaluation of cancer. Optical imaging using near-infrared fluorescence light is a new imaging modality that has recently emerged in the field of cancer imaging. After extensive preclinical research, the first steps of translation to the clinical practice are currently being made. In this article, we discuss the preclinical and clinical results of near-infrared optical imaging for non-invasive detection and classification of tumors, therapy monitoring, sentinel lymph node procedures, and image-guided cancer surgery. Widespread availability of imaging systems and optical contrast agents will enable larger studies on their clinical benefit and can help establish a definitive role in clinical practice.
Export Options
About this article
Cite this article as:
Keereweer Stijn, Hutteman Merlijn, D.F. Kerrebijn Jeroen, J.H. van de Velde Cornelis, L. Vahrmeijer Alexander and W.G.M. Lowik Clemens, Translational Optical Imaging in Diagnosis and Treatment of Cancer, Current Pharmaceutical Biotechnology 2012; 13 (4) . https://dx.doi.org/10.2174/138920112799436294
DOI https://dx.doi.org/10.2174/138920112799436294 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?
Current Topics in Medicinal Chemistry Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Current Pharmaceutical Design BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Anti-Cancer Agents in Medicinal Chemistry Gastrin-Releasing Peptide Receptors Regulate Proliferation of C6 Glioma Cells through a Phosphatidylinositol 3-Kinase-Dependent Mechanism
Current Neurovascular Research Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery Radiogenetic Therapy: Strategies to Overcome Tumor Resistance
Current Pharmaceutical Design Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors
Current Pharmaceutical Design Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Recent Development in the Fabrication of Collagen Scaffolds for Tissue Engineering Applications: A Review
Current Pharmaceutical Biotechnology Potential Interactions between miRNAs and Hypoxia: A New Layer in Cancer Hypoxia
Anti-Cancer Agents in Medicinal Chemistry Human Neural Stem and Progenitor Cells: In Vitro and In Vivo Properties, and Potential for Gene Therapy and Cell Replacement in the CNS
Current Gene Therapy Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells
Current Medicinal Chemistry Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
Current Neuropharmacology Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Current Nanoscience Current Prodrug Design for Drug Discovery
Current Pharmaceutical Design ZIP4 is a Novel Diagnostic and Prognostic Marker in Human Pancreatic Cancer: A Systemic Comparison Between EUS-FNA and Surgical Specimens
Current Molecular Medicine Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology Nitrones: A Potential New Alternative as Therapeutic Agents
Current Organic Chemistry